News Focus
News Focus
icon url

flipper44

01/05/21 10:50 AM

#344929 RE: flipper44 #344926


Part II. Why 90% to 100% Optune compliance "efficacy" effect is illusory and/or not supported by Novocure's data.
(Note: Patients were told to wear device 75% or more per day (aka: 18 hrs or more per day.)

Cherry picking 101. Note: Optune trial never blinded.



icon url

Zadie420

01/05/21 11:10 AM

#344936 RE: flipper44 #344926

Flipp or others- can we superimpose NWBO survival rate against others in OS configuration. Make NWBO different color to show how good DCVAX-L is. Tia

P.S. Then we can send your graph to FDA saying don't waist your time just approve it. Case closed. Picture worth $1M